货号: CL-0007
Price: ¥1600 ¥1600
生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | 4T1(小鼠乳腺癌细胞) |
别称 | 4T1-A |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:3-1:6 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | 4T1细胞是从410.4瘤株中未经诱变筛得的6-硫鸟嘌噙抗性细胞株。当4T1细胞注射到BALB/c小鼠中时,4T1细胞会自发产生高转移肿瘤,可转移到肺、肝、淋巴结和大脑,同时在注射部位形成始发灶,诱导转移时不需要摘除始发灶。4T1细胞在BALB/c小鼠中的生长与转移特性与人体中的乳腺癌十分相近,这种肿瘤是人Ⅵ期乳腺癌的动物模型。4T1细胞诱导的肿瘤在手术后及未手术情况下转移的动力学相近,可以用作手术后及未手术模型。4T1细胞诱导的肿瘤模型跟其他肿瘤模型相比,由于4T1细胞的抗6-硫鸟嘌噙特性,微小的转移细胞团(少到仅仅1个)也可以在许多远端器官中检测到,没必要数淋巴结或称重器官。 |
年龄(性别) | Female |
组织来源 | 乳腺组织 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | BSL-1 |
致瘤性 | Yes, forms tumors and metastasizes in BALB/c mice. |
STR位点信息
STR鉴定图
-
Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties(2024)
作者:Ming Zhang, Yan Chen, Shuaiqi Feng, Yanqin He, Zhifang Liu, Ning Zhang, Qingpeng Wang
期刊:JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1021/acs.jmedchem.4c01265
影响因子:6.8
引用产品: 4T1 细胞, A549/DDP 细胞, Hep G2 细胞, A549 [A-549] 细胞, HL-7702 [L-02; LO2] 细胞
-
Breakthrough of Hypoxia Limitation by Tumor-Targeting Photothermal Therapy-Enhanced Radiation Therapy(2024)
作者:Yi Zhang, Dang Liu, Bin Qiao, Yuanli Luo, Liang Zhang, Yang Cao, Haitao Ran, Chao Yang
期刊:International Journal of Nanomedicine
影响因子:6.6
引用产品: 4T1 细胞
-
Bioactive Nanoliposomes for Enhanced Sonodynamic-Triggered Disulfidptosis-Like Cancer Cell Death via Lipid Peroxidation(2024)
作者:Hongwei Xiang, Bin Shen, Chunmei Zhang, Rui Li
期刊:International Journal of Nanomedicine
影响因子:6.6
引用产品: RPMI-1640 培养基, 4T1细胞专用培养基, 磷酸盐缓冲液(PBS) 1×, 4T1 细胞
-
A Glutathione-Consuming Bimetallic Nano-Bomb with the Combination of Photothermal and Chemodynamic Therapy for Tumors: An in vivo and in vitro Study(2024)
作者:Jing Kong, Jiabin Lai, Min Wang, Yi Xie, Haifei He, Jiayu Gu, Tao Pan, Zhiqiang Lu, Lifeng Jiang
期刊:International Journal of Nanomedicine
影响因子:6.6
引用产品: 4T1 细胞, Hacat 细胞
-
A novel hollow iron nanoparticle system loading PEG-Fe3O4 with C5a receptor antagonist for breast cancer treatment(2024)
作者:Yang Hong, Li Guiqing, Zhang Ji, Zhao Jing, Zhao Yunpei, Wu Yufei, Sun Zihan, Song Shuangshuang, Zou Ying, Zou Zhihao, Han Xiao, Deng Boshao, Wang Lulu, Rao Hang, Xu Guilian, Wang Shufeng, Guo Sheng, Ding Huanyu, Shi Yan, Wu Yuzhang, Chen Jian
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2024.1466180
影响因子:5.7
-
A label-free electrochemical biosensor based on graphene quantum dots-nanoporous gold nanocomposite for highly sensitive detection of glioma cell(2024)
作者:Xiaohui Wang, Xinran Li, Baoquan Wang, Yanxia Xie, Xueru Cui, Jin Jiao, Jianwei Jiao, Yachao Zhang
期刊:ANALYTICA CHIMICA ACTA
影响因子:5.7
引用产品: U251 细胞, NIH/3T3 细胞, SCC7 细胞, 4T1 细胞, B16-F10 细胞, Hela 细胞, Hep G2 细胞, LN229 [LN-229; LNT-229] 细胞, PC-9 细胞, LLC [LL/2; LLC1] 细胞, hCMEC/D3 细胞, HL-7702 [L-02; LO2] 细胞
-
Nanoarchitectonics of Copper Sulfide Nanoplating for Improvement of Computed Tomography Efficacy of Bismuth Oxide Constructs towards Drugless Theranostics(2024)
作者:Meng Ruo-Yin, Xia Hong-Ying, Zhao Ying, Ye Ying-Tong, Wang Shi-Bin, Chen Ai-Zheng, Kankala Ranjith Kumar
期刊:Regenerative Biomaterials
影响因子:5.6
-
Intracellular Delivery of Therapeutic Protein via Ultrathin Layered Double Hydroxide Nanosheets(2024)
作者:He Zhang, Anle Ge, Yulin Wang, Boran Xia, Xichu Wang, Zhonghui Zheng, Changsheng Wei, Bo Ma, Lin Zhu, Rose Amal, Sung Lai Jimmy Yun, Zi Gu
期刊:Pharmaceutics
DOI:10.3390/pharmaceutics16030422
影响因子:5.4
引用产品: 4T1 细胞
-
αO-Conotoxin GeXIVA[1,2] Suppresses In Vivo Tumor Growth of Triple-Negative Breast Cancer by Inhibiting AKT-mTOR, STAT3 and NF-κB Signaling Mediated Proliferation and Inducing Apoptosis(2024)
作者:Xijun Guo, Leping He, Weifeng Xu, Wanrong Wang, Xiaoli Feng, Yuanfeng Fu, Xiaofan Zhang, Ren-Bo Ding, Xingzhu Qi, Jiaolin Bao, Sulan Luo
期刊:Marine Drugs
影响因子:5.4
引用产品: 特级胎牛血清, 青霉素-链霉素溶液(双抗),100×, 4T1 细胞, RPMI-1640 培养基
-
Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeutics(2024)
作者:Fengjie Liu, Yuanyuan Huang, Xiujuan Lin, Qianwen Li, Idoia Gallego, Guoqiang Hua, Nadia Benkirane-Jessel, José Luis Pedraz, Panpan Wang, Murugan Ramalingam, Yu Cai
期刊:Arabian Journal of Chemistry
DOI:10.1016/j.arabjc.2024.105947
影响因子:5.3
引用产品: 4T1 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图